Skip to main content

Table 3 Morphine consumption via PCA, MME consumption, additional analgesic use, and complication rates

From: The effect of body mass index on thoracic paravertebral block analgesia after video-assisted thoracoscopic surgery; a prospective interventional study

 

Group I

(n:25)

Group II

(n:25)

Group III

(n:25)

p

Complication (nausea) n (%)#

-

5 (20.0%)

8 (32.0%)

0.006b, c

Complication (ichting) n (%)#

-

1 (4.0%)

3 (12.0%)

0.315

Additional Analgesic Use n (%)#

1 (4.0%)

8 (32.0%)

13 (52.0%)

0.001a,b

Morphine Consumption via PCA (mg)§

7 (5–13)

18 (6–22)

26 (20–32)

< 0.001b,c

MME consumption (mg)§

7 (5–13)

18 (12–22)

32 (21–45)

< 0.001a,b,c

  1. Continuous variables are expressed as median (Q1-Q3). Categorical variables are expressed as numbers and frequency (percentage). p<0.05 statistically significant. The Conover-Iman Test was performed for binary comparisons among the groups. The P value was set at 0.05
  2. §The Kruskal-Wallis Test;#χ2 test
  3. Significant differences were found between;a: I vs. II;b: I vs. III;c: II vs. III.
  4. MME: Morphine milligram equivalent; PCA: Patient-controlled analgesia